NM_002055.5:c.1171+471C>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002055.5(GFAP):c.1171+471C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0264 in 1,613,924 control chromosomes in the GnomAD database, including 665 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 54 hom., cov: 31)
Exomes 𝑓: 0.027 ( 611 hom. )
Consequence
GFAP
NM_002055.5 intron
NM_002055.5 intron
Scores
6
8
Clinical Significance
Conservation
PhyloP100: 2.96
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0070183575).
BP6
Variant 17-44910144-G-A is Benign according to our data. Variant chr17-44910144-G-A is described in ClinVar as [Benign]. Clinvar id is 66449.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-44910144-G-A is described in Lovd as [Likely_benign]. Variant chr17-44910144-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0212 (3235/152298) while in subpopulation NFE AF= 0.0298 (2030/68038). AF 95% confidence interval is 0.0288. There are 54 homozygotes in gnomad4. There are 1544 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3235 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFAP | NM_002055.5 | c.1171+471C>T | intron_variant | Intron 7 of 8 | ENST00000588735.3 | NP_002046.1 | ||
GFAP | NM_001363846.2 | c.1288C>T | p.Arg430Cys | missense_variant | Exon 8 of 10 | NP_001350775.1 | ||
GFAP | NM_001131019.3 | c.1288C>T | p.Arg430Cys | missense_variant | Exon 8 of 8 | NP_001124491.1 | ||
GFAP | NM_001242376.3 | c.*325C>T | 3_prime_UTR_variant | Exon 7 of 7 | NP_001229305.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0212 AC: 3233AN: 152180Hom.: 54 Cov.: 31
GnomAD3 genomes
AF:
AC:
3233
AN:
152180
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0227 AC: 5652AN: 248848Hom.: 97 AF XY: 0.0231 AC XY: 3129AN XY: 135230
GnomAD3 exomes
AF:
AC:
5652
AN:
248848
Hom.:
AF XY:
AC XY:
3129
AN XY:
135230
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0269 AC: 39335AN: 1461626Hom.: 611 Cov.: 33 AF XY: 0.0269 AC XY: 19558AN XY: 727104
GnomAD4 exome
AF:
AC:
39335
AN:
1461626
Hom.:
Cov.:
33
AF XY:
AC XY:
19558
AN XY:
727104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0212 AC: 3235AN: 152298Hom.: 54 Cov.: 31 AF XY: 0.0207 AC XY: 1544AN XY: 74464
GnomAD4 genome
AF:
AC:
3235
AN:
152298
Hom.:
Cov.:
31
AF XY:
AC XY:
1544
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
106
ALSPAC
AF:
AC:
90
ESP6500AA
AF:
AC:
19
ESP6500EA
AF:
AC:
228
ExAC
AF:
AC:
2806
Asia WGS
AF:
AC:
27
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2Other:1
-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance: not provided
Review Status: no classification provided
Collection Method: literature only
- -
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
not specified Benign:1
Jun 29, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PROVEAN
Uncertain
.;N
REVEL
Uncertain
Sift
Uncertain
.;D
Sift4G
Uncertain
.;D
Vest4
0.039
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at